H. Thomas

H. Thomas, S. Taylor-Robinson, M. Bassendine, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Precore and X region mutants in hepatitis B virus infections among renal dialysis patients

H. Thomas, N. Horiike, W. Carman, 1995, Journal of viral hepatitis.

Analysis of hepatitis virus dna in the liver and serum of hbe antigen positive chimpanzee carriers

A. Zuckerman, H. Thomas, I. Weller, 1982, Journal of medical virology.

Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.

H. Thomas, S. Taylor-Robinson, Shahid A. Khan, 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

The expression of hepatitis B virus polymerase in hepatocytes during chronic HBV infection

H. Thomas, R. Goldin, P. Karayiannis, 1996, Journal of viral hepatitis.

Failure to detect nucleic acid homology between some non‐A, Non‐B viruses and hepatitis B virus DNA

A. Zuckerman, H. Thomas, P. Karayiannis, 1983, Journal of medical virology.

Cloning and analysis of integrated hepatitis B virus DNA of the adr subtype derived from a human primary liver cell carcinoma.

H. Thomas, J. Monjardino, M. Fowler, 1986, The Journal of general virology.

How should we manage the patient?

H. Thomas, J. Main, H. Thomas, 2004 .

Association of hepatitis B surface antigen carriage with severe malaria in Gambian children

D. Kwiatkowski, H. Whittle, H. Thomas, 1995, Nature Medicine.

Psychosocial impact of chronic infection with hepatitis B virus on British patients.

S. Sherlock, A. Lok, H. Thomas, 1985, Genitourinary medicine.

Erratum: Heterozygote advantage for HLA class-II type in hepatitis B virus infection

H. Thomas, B. Greenwood, A. Hill, 1998, Nature Genetics.

Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice

S. Sherlock, H. Thomas, M. Bassendine, 1980 .

Homology between HBV‐DNA and a sequence regulating the interferon‐induced antiviral system: Possible mechanism of persistent infection

H. Thomas, M. Pignatelli, H. Thomas, 1986, Journal of medical virology.

Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.

H. Thomas, M. Pignatelli, A. Lever, 1986, Journal of hepatology.

The detection of hbv‐dna in serum by molecular hybridisation: A more sensitive method for the detection of complete hbv particles

H. Thomas, I. Weller, M. Fowler, 1982, Journal of medical virology.

T‐cell subsets in autoimmune and HBV‐induced chronic liver disease: a review of the abnormalities and the effects of treatment

H. Thomas, O. Epstein, David Brown, 2008 .

The immune response in hepatic cirrhosis: animal and human studies.

H. Thomas, H. Thomas, 1977, Proceedings of the Royal Society of Medicine.

Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency

H. Thomas, S. Taylor-Robinson, M. Bassendine, 2014, Metabolic Brain Disease.

Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

M. Manns, C. Trautwein, H. Thomas, 1996, Hepatology.

Serological respo etedion of virae acute hepatitis C virus infection

H. Thomas, J. Chiba, T. Miyamura, 1992 .

Inducer and Suppressor T‐Cells in Hepatitis B Virus‐induced Liver Disease

H. Thomas, G. Janossy, David Brown, 2007, Hepatology.

T cell subsets in patients with acute and chronic HBV infection, primary biliary cirrhosis and alcohol induced liver disease.

H. Thomas, H. Thomas, 1981, International journal of immunopharmacology.

Complement inhibition rescued mice allowing observation of transgene expression following intraportal delivery of baculovirus in mice

H. Thomas, C. Coutelle, S. Waddington, 2005, The journal of gene medicine.

Sequence, expression and reconstitution of an HCV genome from a British isolate derived from a single blood donation

H. Thomas, U. Kumar, J. Monjardino, 2000, Journal of viral hepatitis.

Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection.

H. Thomas, U. Kumar, J. Monjardino, 1993, The Journal of infectious diseases.

Cloning and sequencing of the structural region and expression of putative core gene of hepatitis C virus from a British case of chronic sporadic hepatitis.

H. Thomas, U. Kumar, J. Monjardino, 1992, The Journal of general virology.

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

P. Andersen, H. Thomas, G. Gerken, 1994, Journal of hepatology.

PTU-049 Rate of disease progression and the influence of co-factors in hepatitis C virus as determined by interval liver biopsy

H. Thomas, R. Goldin, M. Thursz, 2010, Gut.

INTERFERONS AS MEDIATORS OF PSYCHIATRIC MORBIDITY An Investigation in a Trial of Recombinant α-Interferon in Hepatitis-B Carriers

H. Thomas, A. Mann, E. Mcdonald, 1987, The Lancet.

Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma.

J. Whittaker, H. Thomas, S. Taylor-Robinson, 2019, Journal of clinical and experimental hepatology.

Hepatitis B Virus and HLA Antigen Display in the Liver During Chronic Hepatitis B Virus Infection

H. Thomas, A. Goodall, G. Janossy, 2007, Hepatology.

IN-VITRO SYNTHESIS OF ANTI-ACETYLCHOLINE-RECEPTOR ANTIBODY BY THYMIC LYMPHOCYTES IN MYASTHENIA GRAVIS

G. Scadding, H. Thomas, A. Vincent, 1978, The Lancet.

Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence.

H. Whittle, H. Thomas, J. Bell, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Interferon therapy is effective in treatment of hepatitis B-induced polyarthritis

H. Thomas, P. Karayiannis, L. Scully, 1992, Digestive Diseases and Sciences.

Variations due to analysis technique in intracellular pH measurements in simulated and in vivo 31P MR spectra of the human brain

J. Hajnal, J. Allsop, H. Thomas, 2006, Journal of magnetic resonance imaging : JMRI.

IS PRIMARY BILIARY CIRRHOSIS AN IMMUNE COMPLEX DISEASE?

S. Sherlock, H. Thomas, B. Potter, 1977, The Lancet.

CHAPTER 48 – Hepatitis

H. Thomas, J. Main, H. Thomas, 2010 .

Current Status of Hepatitis G Virus (GBV‐C) in Transfusion: Is It Relevant?

H. Thomas, P. Karayiannis, H. Thomas, 1997, Vox sanguinis.

Hepatitis C virus type I(1a) in Northern China

H. Thomas, J. Niu, Y. Liu, 1995, Journal of medical virology.

Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease

H. Thomas, J. Chiba, T. Miyamura, 1992, Hepatology.

Parenterally acquired non-A non-B hepatitis ten years on: advances in diagnosis and therapy.

H. Thomas, M. Jacyna, H. Thomas, 1990, Postgraduate medical journal.

Neutralization of Hepatitis B Virus Infectivity by a Murine Monoclonal Antibody: An Experimental Study in the Chimpanzee

H. Thomas, A. Goodall, S. Iwarson, 1985, Journal of medical virology.

Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B hepatic viral antigen display.

H. Thomas, J. Mcdonald, J. Waters, 1987, Journal of hepatology.

Serum HBV DNA detected by PCR in dot blot negative HBV chronic carriers with active liver disease.

H. Thomas, J. Velosa, M. D. de Moura, 1991, Journal of hepatology.

Modern progress in hepatic encephalopathy.

M. Mcphail, H. Thomas, S. Taylor-Robinson, 2010, QJM : monthly journal of the Association of Physicians.

ANTI-HIV EFFECTS OF ALPHA-INTERFERON

H. Thomas, M. Brook, D. Gor, 1989, The Lancet.

Protection against hepatitis B virus infection by immunization with hepatitis B core antigen.

H. Thomas, S. Iwarson, P. Snoy, 1985, Gastroenterology.

Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

H. Thomas, R. G. White, R. N. Mcsween, 1973, Lancet.

Editing efficiency of hepatitis delta virus RNA is related to the course of infection in woodchucks.

H. Thomas, P. Karayiannis, J. Monjardino, 1995, The Journal of general virology.

Human hepatocellular carcinoma: Cross‐reactive and idiotypic antigens associated with malignant transformation of epithelial cells

H. Thomas, J. Southgate, L. Trejdosiewicz, 1987, Hepatology.

A randomized study of the effects of adenine arabinoside 5′‐monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication

H. Thomas, P. Karayiannis, A. Dunk, 1985, Hepatology.

Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.

A. Lok, H. Thomas, S. Hadziyannis, 1984, Gut.

Analysis of the molecular state of HBV-DNA in the liver and serum of patients with chronic hepatitis or primary liver cell carcinoma and the effect of therapy with adenine arabinoside.

A. Lok, H. Thomas, I. Weller, 1984, Gut.

Inhibition of hepatitis B viral replication by lymphoblastoid interferon.

S. Sherlock, H. Thomas, I. Weller, 1982, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature

M. Manns, H. Thomas, S. Sauleda, 2000 .

Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research.

M. Manns, H. Thomas, S. Sauleda, 2000, European journal of gastroenterology & hepatology.

Natural killer cell activity in hepatocellular carcinoma. In vitro and in vivo responses to interferon.

H. Thomas, A. Dunk, D. Novick, 1987, Scandinavian journal of gastroenterology.

Therapies for Viral Hepatitis

H. Thomas, R. Schinazi, J. Sommadossi, 1998 .

Molecular Variants of Hepatitis B Surface Antigen (HBsAg)

S. Alavian, H. Thomas, S. Jazayeri, 2013 .

NICE Guidelines and a Treatment Algorithm for the Management of Chronic Hepatitis B: A Review of 12 Years Experience in West London

H. Thomas, M. Thursz, Ashley S. Brown, 2008, Antiviral therapy.

Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease?

H. Thomas, P. Karayiannis, 2005, Nature Clinical Practice Gastroenterology &Hepatology.

The Role of the Liver in Immunological Disease

H. Thomas, H. Thomas, 1977 .

The mechanism of replication of hepatitis B virus: Evidence of asymmetric replication of the two DNA strands

A. Zuckerman, H. Thomas, K. Tsiquaye, 1984, Journal of medical virology.

Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis

H. Thomas, Roger Williams, W. Carman, 1991, Hepatology.

Immunologic mechanisms of cell lysis in Hepatitis B virus infection.

H. Thomas, A. Goodall, M. Pignatelli, 1984 .

Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

M. Manns, C. Trautwein, H. Thomas, 1996, Hepatology.

Defective response to interferons in cells transfected with the hepatitis B virus genome

H. Thomas, M. Onji, I. Saito, 1989, Hepatology.

Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.

A. Lok, H. Thomas, P. Karayiannis, 1985, Journal of hepatology.

Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.

S. Sherlock, H. Thomas, A. Craxì, 1983, Gut.

DETECTION OF HBV-DNA BY MOLECULAR HYBRIDIZATION - A MORE SENSITIVE METHOD FOR DETECTION OF HBV PARTICLES IN SERUM

H. Thomas, A. Craxì, I. Weller, 1981 .

Treatment of chronic hepatitis B infection.

H. Thomas, J. Main, H. Thomas, 1990, Pharmacology & therapeutics.

Management of chronic hepatitis C: clinical audit of biopsy based management algorithm

H. Thomas, R. Goldin, I. Murray-Lyon, 1997 .

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.

H. Thomas, D. Tyrrell, F. Nevens, 1997, Gastroenterology.

The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference

M. Buti, H. Thomas, F. Roudot-thoraval, 2013, Journal of viral hepatitis.

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

A. Bhalla, H. Thomas, F. Nevens, 1997, Gastroenterology.

The management of chronic hepatitis C virus infection.

H. Thomas, H. Thomas, J. Brown, 1995, Gut.

Treatment of Chronic Viral Hepatitis

H. Thomas, J. Main, M. Wright, 1998, Antiviral chemistry & chemotherapy.

Quantitative hepatitis B virus DNA assessment by the limiting‐dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy

H. Thomas, D. Tyrrell, F. Nevens, 1998, Journal of viral hepatitis.

Summary of the III International Consensus Symposium on Combined Antiviral Therapy.

D. Richman, H. Thomas, D. Cooper, 1998, Antiviral research.

Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.

Jennifer A. Roberts, R. Grieve, H. Thomas, 2006, Health technology assessment.

NON-A, NON-B HEPATITIS OCCURRING IN AGAMMAGLOBULINAEMIC PATIENTS AFTER INTRAVENOUS IMMUNOGLOBULIN

H. Thomas, David Brown, A. Webster, 1984, The Lancet.

The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity.

H. Thomas, R. N. Macsween, H. Folch, 1976, Clinical and experimental immunology.

Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP‐2, with outcome of HCV infection

J. Satsangi, P. Klenerman, H. Thomas, 2003, Hepatology.

Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients

H. Thomas, D. Webster, Umesh Kumar, 1998, Hepatology.

Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.

H. Thomas, D. Concas, R. Goldin, 2010, Journal of hepatology.

Liver Membrane Antibodies Detected by Immunoradiometric Assay in Acute and Chronic Virus‐Induced and Autoimmune Liver Disease

H. Thomas, David Brown, D. Brown, 1984, Hepatology.

Hepatitis B virus and host cell membrane antigens on a primary hepatocellular carcinoma cell line.

Z. Varghese, H. Thomas, A. Goodall, 2008, Liver.

Defective hepatitis B virus DNA molecules detected in a stable integration pattern in a hepatoma cell line, and in induced tumours and derived cell lines.

H. Thomas, J. Monjardino, M. Fowler, 1983, The Journal of general virology.

Is mitochondrial antibody diagnostic of primary biliary cirrhosis?

S. Sherlock, H. Thomas, D. Doniach, 1981, Gut.

Approaches to the Treatment of Hepatitis B Virus and Delta-Related Liver Disease

H. Thomas, M. Pignatelli, A. Lever, 1986, Seminars in liver disease.

Quantitative versus morphological assessment of liver fibrosis: semi‐quantitative scores are more robust than digital image fibrosis area estimation

H. Thomas, R. Goldin, M. Thursz, 2003, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis G virus: identification, prevalence and unanswered questions.

H. Thomas, P. Karayiannis, 1997, Gut.

Studies of GB hepatitis agent in tamarins

H. Thomas, Peter Karayiannis, Lidija M. Petrovic, 1989, Hepatology.

Intraperitoneal haemorrhage from anterior abdominal wall varices.

H. Thomas, M. Appleyard, M. Thursz, 1993, Postgraduate medical journal.

Immunological Aspects of Liver Disease

H. Thomas, H. J. Muller-Eberhard, P. Miescher, 1982, Springer Berlin Heidelberg.

The hepatitis B virus and the host response.

H. Thomas, H. Thomas, 1990, Journal of hepatology.

The immune response in cirrhotic rats. The induction of tolerance to orally administered protein antigens.

H. Thomas, R. N. Macsween, L. Blumgart, 1976, Gastroenterology.

Enterically Transmitted Viral Hepatitis: Hepatitis A and Hepatitis E

H. Thomas, P. Karayiannis, 2011 .

Pathogenic mechanisms in primary biliary cirrhosis

H. Thomas, O. Epstein, H. Thomas, 1980, Springer Seminars in Immunopathology.

Potential Pathogenic Mechanisms in Primary Biliary Cirrhosis

H. Thomas, H. Thomas, 1981, Seminars in liver disease.

Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant.

H. Thomas, R. Goldin, P. Karayiannis, 1995, Journal of hepatology.

MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION

H. Thomas, W. Carman, S. Hadziyannis, 1989, The Lancet.

Molecular Variants of the Precore, Core, and Core Promoter Regions of Hepatitis B Virus, and Their Clinical Significance

H. Thomas, W. Carman, P. Karayiannis, 2013 .

Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR

H C Thomas, H. Thomas, A. Hill, 2003, Genes and Immunity.

A double blind, placebo‐controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

H. Thomas, J. Main, P. Karayiannis, 1996, Journal of viral hepatitis.

Which patients with chronic hepatitis B virus infection will respond to α‐interferon therapy? A statistical analysis of predictive factors

H. Thomas, M. Brook, P. Karayiannis, 1989, Hepatology.

Mechanisms of action of interferon and nucleoside analogues.

H. Thomas, G. Foster, D. Platis, 2003, Journal of hepatology.

Incidence of hepatitis B viraemia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon–α

H. Thomas, W. Carman, P. Karayiannis, 1991, Journal of medical virology.

Treatment of hepatitis B virus infection with interferon. Factors predicting response to interferon.

H. Thomas, G. Brook, P. Karayiannis, 1991, Journal of hepatology.

The hepatitis B virus.

H. Thomas, W. Carman, J. Brown, 1990, Bailliere's clinical gastroenterology.

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.

H. Thomas, I. Murray-Lyon, J. Main, 1989, BMJ.

Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum

H. Thomas, C. Chu, Y. Liaw, 1985, Hepatology.

Hepatitis B virus precore/core variation and interferon therapy

H. Thomas, G. Fattovich, A. Alberti, 1995, Hepatology.

Best practice in the treatment of chronic hepatitis B: a summary of the European Viral Hepatitis Educational Initiative (EVHEI).

H. Thomas, Howard C Thomas, H. Thomas, 2007, Journal of hepatology.

Hepatitis B Virus: General Features

H. Thomas, P. Karayiannis, H. Thomas, 2008 .

The emergence of envelope and precore/core variants of hepatitis B virus: the potential role of antibody selection.

H. Thomas, 1995, Journal of Hepatology.

Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration.

Z. Varghese, S. Sherlock, H. Thomas, 1983, The Journal of antimicrobial chemotherapy.

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

S. Sherlock, H. Thomas, A. Craxì, 1982, Gut.

Effect of basal core promoter and pre-core mutations on hepatitis B virus replication.

H. Thomas, R. Watson, P. Karayiannis, 2008, The Journal of general virology.

Antiviral therapy: hepatitis B.

H. Thomas, M. Jacyna, M. R. Jacyna, 1990, British medical bulletin.

Immunological studies before and during interferon therapy in chronic HBV infection: Identification of factors predicting response

H. Thomas, David Brown, H. Thomas, 1990, Hepatology.

Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment.

H. Thomas, P. Karayiannis, S. Kanatakis, 1990, Journal of hepatology.

Acute and chronic hepatitis delta virus infection: Direct or indirect effect on hepatitis B virus replication?

H. Thomas, F. Marongiu, P. Farci, 1988, Journal of medical virology.

Thomas Methods PATIENTS Between August 1980 and November 1981 , all patients who had been HBsAg and HBeAg positive for more than six months attending the Department of Medicine at the Royal Free

S. Sherlock, H. Thomas, A. Mindel, 2022 .

Hepatitis B Surface Antigen (HBsAg) Variants

H. Thomas, A. Basuni, W. Carman, 2007 .

Molecular Variations in the Core Promoter, Precore and Core Regions of Hepatitis B Virus, and their Clinical Significance

H. Thomas, W. Carman, P. Karayiannis, 2007 .

Hepatitis B and D

H. Thomas, 2002 .

Genetic variation in hepatitis B virus.

H. Thomas, W. Carman, 1992, Gastroenterology.

A pilot study of BW A515U (6-deoxyacyclovir) in chronic hepatitis B virus infection.

H. Thomas, R. Tedder, P. Karayiannis, 1986, Journal of Hepatology.

An in situ hybridization, molecular biological and immunohistochemical study of hepatitis delta virus in woodchucks

H. Thomas, Peter Karayiannis, Spyros Dourakis, 1991, Hepatology.

Effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen

H. Thomas, R. Gehrke, P. Karayiannis, 2000, Journal of medical virology.

Biological standards for hepatitis B virus assays.

H. Thomas, G. Gerken, C. Bréchot, 1992, Journal of hepatology.

Corrigendum to ‘‘Mechanisms of action of interferon and nucleoside analogues’’ [J Hepatol 39 (2003) S93–S98]

H. Thomas, G. Foster, D. Platis, 2004 .

A unique insertion in the S gene of surface antigen–negative hepatitis B virus Chinese carriers

H. Thomas, P. Karayiannis, J. Hou, 1995, Hepatology.

Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom.

H. Thomas, G. Hill-Cawthorne, L. Sawyer, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The host immune response may be responsible for selection of envelope and precore/core variants of HBV.

H. Thomas, W. Carman, H. Thomas, 1992, Progress in liver diseases.

Antiviral therapy: hepatitis B.

H. Thomas, M. Jacyna, 1990, British medical bulletin.

Mapping of 5' ends of virion-derived HBV DNA.

H. Thomas, J. Saldanha, J. Monjardino, 1992, Virology.

Cost effectiveness of interferon α or peginterferon α with ribavirin for histologically mild chronic hepatitis C

Jennifer A. Roberts, R. Grieve, H. Thomas, 2005, Gut.

Pathophysiology and Treatment of Hepatitis C

H. Thomas, J. Brown, J. Booth, 2012, Drugs.

Replicative competence of the T131I, K141E, and G145R surface variants of hepatitis B Virus.

H. Thomas, P. Karayiannis, S. Jammeh, 2007, The Journal of infectious diseases.

Envelope and precore/core variants of hepatitis B virus.

H. Thomas, W. Carman, 1994, Gastroenterology clinics of North America.

Emergence of the long form of hepatitis delta virus antigen in transfected cells after intrahepatic transfection and during natural infection.

H. Thomas, S. Hadziyannis, P. Karayiannis, 1993, Progress in clinical and biological research.

Treatment of chronic hepatitis B virus infection.

H. Thomas, I. Weller, 1983, Clinical and experimental obstetrics & gynecology.

Hepatitis B Virus Infection and Immunity

H. Thomas, M. Thursz, G. Foster, 1998 .

Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection.

H. Thomas, M. Pignatelli, A. Lever, 1986, Gut.

Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance

Maggie Westby, H. Thomas, M. Westby, 2013, BMJ.

Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C.

H. Thomas, S. Taylor-Robinson, D. Forton, 1999, Journal of hepatology.

In situ hybridization studies of hepatitis A viral RNA in patients with acute hepatitis A.

H. Thomas, S. Ladva, R. Goldin, 1994, Journal of hepatology.

Hepatitis C and bile duct loss.

H. Thomas, R. Goldin, N. Patel, 1996, Journal of clinical pathology.

Hepatitis C andbile ductloss

H. Thomas, R. Goldin, N. Patel, 1996 .

Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: A phosphorus-31 MR spectroscopy study

H. Thomas, S. Taylor-Robinson, G. Coutts, 2000, Metabolic Brain Disease.

Effects of hepatitis B and hepatitis C virus replication on the actions of interferon.

H. Thomas, G. Foster, 1994, Antiviral research.

Treatment of Hepatitis C with Interferon: Mechanism of Action of Interferon

H. Thomas, G. Foster, H. Thomas, 1994 .

Recent advances in the molecular biology of hepatitis B virus: mutant virus and the host response.

H. Thomas, G. Foster, H. Thomas, 1993, Gut.

Clinical and histological features of delta infection in chronic hepatitis B virus carriers.

A. Lok, H. Thomas, I. Lindsay, 1985, Journal of clinical pathology.

Interferon (IFN)-α2 Genotype Analysis of Chinese Chronic Hepatitis B Patients Undergoing Recombinant IFN-α2a Therapy

A. Lok, H. Thomas, M. Thursz, 1994 .

Immunological and anti-viral therapy of chronic hepatitis B virus infection.

H. Thomas, M. Bassendine, H. Thomas, 1980, Clinics in gastroenterology.

Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.

A. Lok, H. Thomas, G. Dusheiko, 1994, Journal of viral hepatitis.

Hepatitis B viral infection.

H. Thomas, 1988, The American journal of medicine.

Replicative Competence of the T 131 I , K 141 E , and G 145 R Surface Variants of Hepatitis B Virus

H. Thomas, S. Jammeh, H. Thomas, 2007 .

Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers: implications for the treatment of chronic HBV carriers.

H. Thomas, 1989, The Quarterly journal of medicine.

Host Factors in Chronic Viral Hepatitis

H. Thomas, M. Thursz, H. Thomas, 1997, Seminars in liver disease.

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

J. Allsop, H. Thomas, S. Taylor-Robinson, 2002, Hepatology.

In situ hybridization studies in hepatitis A infection

H. Thomas, R. Goldin, P. Karayiannis, 1992, Hepatology.

Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection

H. Thomas, J. Saldanha, J. Main, 1990, Hepatology.

Cloning and sequencing of RNA of hepatitis delta virus isolated from human serum.

H. Thomas, J. Saldanha, J. Monjardino, 1990, The Journal of general virology.

Cloning and expression of an immunodominant region of the hepatitis delta antigen.

H. Thomas, J. Saldanha, R. Goldin, 1990, The Journal of general virology.

Pre‐S proteins in hepatitis b

A. Zuckerman, H. Thomas, A. Zanetti, 1989, Journal of medical virology.

Heterozygote advantage for HLA class-II type in hepatitis B virus infection

H. Thomas, B. Greenwood, A. Hill, 1997, Nature Genetics.

Evidence for a cerebral effect of the hepatitis C virus

J. Allsop, H. Thomas, S. Taylor-Robinson, 2001, The Lancet.

Changing international trends in mortality rates for liver, biliary and pancreatic tumours.

H. Thomas, S. Taylor-Robinson, Shahid A. Khan, 2002, Journal of hepatology.

Hepatic stem cells.

H. Thomas, R. Poulsom, S. Forbes, 2002, The Journal of pathology.

Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection

P. Klenerman, H. Thomas, A. Hill, 2002, Genes and Immunity.

Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study.

J. Allsop, H. Thomas, S. Taylor-Robinson, 2008, Journal of hepatology.

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

H. Thomas, S. Taylor-Robinson, N. Heaton, 2012, Gut.

Influence of MHC class II genotype on outcome of infection with hepatitis C virus

Mark Thursz, Christian Trepo, H. Thomas, 1999, The Lancet.

The factor V Leiden mutation accelerates disease progression in a mouse model of hepatic fibrosis induced by chronic carbon tetrachloride exposure

H. Thomas, R. Goldin, M. Thursz, 2004 .

The relationship of histology to genotype in chronic HCV infection.

H. Thomas, R. Goldin, G. Foster, 2008, Liver.

Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trial

H. Thomas, R. Tedder, R. Goldin, 2005, Journal of viral hepatitis.

Genetic diversity between hepatitis G virus isolates: analysis of nucleotide variation in the NS-3 and putative 'core' peptide genes.

H. Thomas, P. Karayiannis, J. Pickering, 1997, The Journal of general virology.

Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response.

H. Thomas, G. Foster, C. Laxton, 1999, Gastroenterology.

New insights into hepatitis

H. Thomas, M. Thursz, S. Knapp, 2012 .

Hepatitis C and hepatic steatosis.

H. Thomas, S. Taylor-Robinson, J. Cobbold, 2010, QJM : monthly journal of the Association of Physicians.

Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease.

H. Thomas, A. Lim, S. Taylor-Robinson, 2006, World journal of gastroenterology.

New insights into hepatitis C.

H. Thomas, S. Taylor-Robinson, M. Thursz, 2002, Clinical medicine.

Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants

H. Thomas, S. Taylor-Robinson, D. Forton, 2004, Journal of Virology.

Hepatitis C virus replication in hepatocellular carcinoma.

H. Thomas, R. Goldin, J. Niu, 1995, Journal of clinical pathology.

Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma.

H. Thomas, S. Taylor-Robinson, Shahid A. Khan, 2006, International journal of oncology.

p53 mutations in human cholangiocarcinoma: a review

H. Thomas, S. Taylor-Robinson, Shahid A. Khan, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?

H. Thomas, R. Lechler, A. Godkin, 2008, The Journal of allergy and clinical immunology.

Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-alpha.

H. Thomas, M. Thursz, A. Luik, 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects

H. Thomas, P. Karayiannis, T. Petropoulou, 2003, Journal of medical virology.

Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection

P. Klenerman, H. Thomas, A. Hill, 2007, Genes and Immunity.

T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment.

H. Thomas, O. Epstein, J. Labrooy, 1982, Journal of clinical immunology.

Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis.

H. Thomas, J. Jones, D. Peacock, 1976, Gut.

Evolution of Epitope-Specific Memory CD4+ T Cells After Clearance of Hepatitis C Virus

H. Thomas, P. Openshaw, A. Godkin, 2002, The Journal of Immunology.

T Cells After Clearance of Hepatitis C Virus + Evolution of Epitope-Specific Memory CD 4 Openshaw

H. Thomas, P. Openshaw, A. Godkin, 2002 .

The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference *

M. Buti, H. Thomas, J. Bruix, 2011, Journal of viral hepatitis.

Increase in primary liver cancer in the UK, 1979–94

H. Thomas, S. Taylor-Robinson, G. Foster, 1997, The Lancet.

NON-A, NON-B HEPATITIS AFTER INTRAVENOUS GAMMAGLOBULIN

H. Thomas, A. Webster, D. Brown, 1985, The Lancet.

Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998

H. Thomas, S. Taylor-Robinson, Shahid A. Khan, 2001, Gut.

Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?

H. Thomas, S. Taylor-Robinson, Shahid A. Khan, 2012, Journal of hepatology.

Central Nervous System Involvement in Hepatitis C Virus Infection

H. Thomas, S. Taylor-Robinson, D. Forton, 2004, Metabolic Brain Disease.

Long‐term follow‐up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver‐related complications

H. Thomas, S. Sauleda, A. Alberti, 2007, Journal of viral hepatitis.

Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency.

H. Thomas, G. Stark, G. Foster, 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Pathogenesis and diagnosis of hepatic encephalopathy

M. Mcphail, H. Thomas, S. Taylor-Robinson, 2010, Expert review of gastroenterology & hepatology.

Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study.

A. Lok, H. Thomas, I. Murray-Lyon, 1985, Journal of hepatology.

Abnormal T-lymphocyte subsets in hemophilia: relation to HLA proteins in plasma products.

H. Thomas, P. Karayiannis, C. Lee, 1984, The New England journal of medicine.

Genetic Factors in the Pathogenesis of Cholangiocarcinoma

Stephen P. Pereira, Jason H. Wong, Michael H. Chapman, 2011, Digestive Diseases.

Hepatitis D virus antibody in HBsAg‐positive and HBsAg‐negative substance abusers with chronic liver disease

H. Thomas, M. Kreek, P. Farci, 1985, Journal of medical virology.

264 COMMON GENETIC VARIATION IN NATURAL KILLER CELL RECEPTOR PROTEIN G2D DOES NOT MODIFY SUSCEPTIBILITY TO SPORADIC CHOLANGIOCARCINOMA

J. Whittaker, H. Thomas, S. Taylor-Robinson, 2011 .

Perihepatic lymph nodes as markers of disease response in patients with hepatitis C-related liver disease: a prospective clinical evaluation

H. Thomas, A. Lim, S. Taylor-Robinson, 2010, European journal of gastroenterology & hepatology.

Pseudomembranous colitis following clarithromycin therapy.

H. Thomas, J. Teare, J. Martin, 1995, European journal of gastroenterology & hepatology.

Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study

H. Thomas, A. Fabre, R. Goldin, 2003, Gut.

Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.

H. Thomas, S. Taylor-Robinson, Shahid A. Khan, 2011, Journal of proteome research.

Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.

H. Thomas, S. Taylor-Robinson, Shahid A. Khan, 2010, Journal of proteome research.

Hepatocellular carcinoma: diagnostics and screening.

H. Thomas, S. Taylor-Robinson, Shahid A. Khan, 2012, Journal of evaluation in clinical practice.

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference

H. Thomas, A. Hatzakis, Y. Tountas, 2016, Journal of viral hepatitis.

British Association for the Study of the Liver

A. Perelson, C. Dejong, Y. Ma, 1991 .

Characterization of stable hepatitis delta expressing hepatoma cell lines: effect of HDAg on cell growth.

H. Thomas, J. Monjardino, D. Cheng, 1993, Progress in clinical and biological research.

Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels

J. Hajnal, A. Oatridge, J. Allsop, 2004, Gut.

Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection

H. Thomas, S. Taylor-Robinson, M. Bassendine, 2010, Gut.

Fatigue in primary biliary cirrhosis

J. Hajnal, A. Oatridge, H. Thomas, 2005, Gut.

Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis (PBC)

J. Allsop, H. Thomas, S. Taylor-Robinson, 2002 .

Treatment of thrombocytopenia with alfa interferon.

H. Thomas, M. Brook, A. Lever, 1987, British medical journal.

Management of recurrent bleeding from facial arteriovenous malformations in end-stage liver disease

S. T. Robinson, H. Thomas, Shahid A. Khan, 2010 .

DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma

H. Thomas, S. Taylor-Robinson, P. Carmichael, 2003, Gut.

Accuracy and reliability of microbubble ultrasound measurements for the non‐invasive assessment of hepatic fibrosis in chronic hepatitis C

H. Thomas, J. Fitzpatrick, S. Taylor-Robinson, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Ablative therapy for liver tumours

H C Thomas, W. Gedroyc, H. Thomas, 2002, Gut.

Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue.

R. Cox, H. Thomas, S. Taylor-Robinson, 2009, Clinical science.

Gallbladder Cancer Presenting with Trousseau's Sign in a 31-Year-Old Man with Occupational Exposure to Aromatic Hydrocarbons

H. Thomas, M. Jacyna, P. Diggory, 1989, Journal of the Royal Society of Medicine.

Optimal combinations of ultrasound‐based and serum markers of disease severity in patients with chronic hepatitis C

H. Thomas, J. Fitzpatrick, S. Taylor-Robinson, 2009, Journal of viral hepatitis.

Hepatic vein transit time of SonoVue: a comparative study with Levovist.

H. Thomas, A. Lim, S. Taylor-Robinson, 2006, Radiology.

Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C

D O Cosgrove, H C Thomas, H. Thomas, 2004, Gut.

Bronchobiliary fistula due to acute cholecystitis in a suprahepatic gall bladder.

H. Thomas, A. Burroughs, M. Allison, 1987, Postgraduate medical journal.

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP).

G Realdi, H. Thomas, F. Nevens, 1997, Journal of hepatology.

Pathogenesis of chronic hepatitis C and associated clinical manifestations.

H. Thomas, J. Booth, H. Thomas, 1996, Bailliere's clinical gastroenterology.

Central Nervous System Complications of Hepatitis C Virus Infection

H. Thomas, S. Taylor-Robinson, D. Forton, 2013 .

LIVER Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis

H. Thomas, S. Taylor-Robinson, D. Cosgrove, 2004 .

EXPRESSION OF BETA-2-MICROGLOBULIN ON HEPATOCYTES AFTER LIVER TRANSPLANTATION

H. Thomas, P. Scheuer, Y. Nagafuchi, 1985, The Lancet.

Lipid profiling of pre‐treatment liver biopsy tissue predicts sustained virological response in patients with chronic hepatitis C

H. Thomas, S. Taylor-Robinson, R. Goldin, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Therapy for chronic viral hepatitis: current indications, optimal therapies and delivery of care.

H. Thomas, G. Foster, M. Cowan, 2011, Clinical medicine.

Viral Hepatitis: Fourth Edition

A. Zuckerman, H. Thomas, A. Lok, 2013 .

The Role of Liver Fibrosis Assessment in the Management of Patients with Chronic Hepatitis B Infection: Lessons Learned from a Single Centre Experience

H. Thomas, R. Goldin, M. Thursz, 2011, Hepatitis research and treatment.

Delta hepatitis in Lebanon. Prevalence studies and a report on six siblings with chronic delta-positive active hepatitis.

H. Thomas, A. Burroughs, P. Farci, 1987, Journal of hepatology.

Reduced quality of life in hepatitis C--is it all in the head?

H. Thomas, S. Taylor-Robinson, D. Forton, 2002, Journal of hepatology.

Monoclonal antibody to HBsAg for chronic hepatitis B virus infection with hypogammaglobulinaemia

H. Thomas, M. Brook, P. Karayiannis, 1990, The Lancet.

Non-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques.

H. Thomas, S. Taylor-Robinson, M. Wylezinska, 2006, Gut.

Expression, purification, and partial characterization of HCV RNA polymerase.

H. Thomas, Y. Wen, U. Kumar, 1997, Biochemical and biophysical research communications.

In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of 1H and 31P MRS applications

H. Thomas, S. Taylor-Robinson, G. Hamilton, 2005 .

Does the precore mutant of hbv cause fulminant hepatitis?

H. Thomas, 1992, Hepatology.

Liver stiffness measurements in acute hepatitis B: implications for clinical practice.

H. Thomas, S. Taylor-Robinson, J. Cobbold, 2010, European journal of gastroenterology & hepatology.

Integration of hepatitis B virus DNA through a mutational hot spot within the cohesive region in a case of hepatocellular carcinoma.

H. Thomas, J. Saldanha, J. Monjardino, 1992, The Journal of general virology.

Central nervous system changes in hepatitis C virus infection.

H. Thomas, S. Taylor-Robinson, D. Forton, 2006, European journal of gastroenterology & hepatology.

A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection.

J. Allsop, H. Thomas, S. Taylor-Robinson, 2005, AIDS.

In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.

H. Thomas, S. Taylor-Robinson, G. Hamilton, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon alfa therapy

H. Thomas, G. Foster, M. Török, 1999, Hepatology.

Hepatitis-B-vaccine

H. Thomas, W. Carman, 1985, Reactions Weekly.

Viral Hepatitis: Scientific Basis and Clinical Management

A. Zuckerman, H. Thomas, H. Thomas, 1993 .

Therapeutic options for HCV--management of the infected individual.

H. Thomas, G. Foster, H. Thomas, 2000, Bailliere's best practice & research. Clinical gastroenterology.

Haemorrhagic pancreatitis--a cause of death in severe potassium permanganate poisoning.

H. Thomas, M. Jacyna, S. Middleton, 1990, Postgraduate medical journal.

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C

H. Thomas, F. Nevens, G. Realdi, 1997 .

Chronic hepatitis B.

H. Thomas, S. Hadziyannis, S. Schalm, 1990, Progress in liver diseases.

Hepatic lipid profiling in chronic hepatitis C: an in vitro and in vivo proton magnetic resonance spectroscopy study.

H. Thomas, J. Fitzpatrick, S. Taylor-Robinson, 2010, Journal of hepatology.

Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency

H. Thomas, S. Taylor-Robinson, M. Bassendine, 2014, Metabolic Brain Disease.

Mild hepatitis C: treat or monitor

H. Thomas, J. Main, 2006, Journal of viral hepatitis.

Influence of sexual preference and chronic hepatitis B virus infection on T lymphocyte subsets, natural killer activity, and suppressor cell activity.

A. Lok, H. Thomas, H. Thomas, 1986, Journal of hepatology.

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.

H. Thomas, O. Weiland, G. Norkrans, 1996, Journal of hepatology.

Influence of IL‐10RA and IL‐22 polymorphisms on outcome of hepatitis C virus infection

H. Thomas, M. Thursz, B. Hennig, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Hepatocytes derived from bone marrow stem cells demonstrate polyploidisation

H. Thomas, R. Poulsom, S. Forbes, 2001 .

Bone marrow-hepatocytes transdifferentiation: This axis of organ regeneration can be modulated for clinical application

H. Thomas, R. Poulsom, S. Forbes, 2003 .

Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin

H. Thomas, I. Ushiro-Lumb, Shahid A. Khan, 2010, Journal of viral hepatitis.

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

H. Thomas, R. Goldin, G. Foster, 1998, Hepatology.

Minocycline and hepatitis

H. Thomas, R. Goldin, J. Leonard, 1996, Clincal and Experimental Dermatology.

Cerebral dysfunction in chronic hepatitis C infection

H. Thomas, S. Taylor-Robinson, D. Forton, 2003, Journal of viral hepatitis.

Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis

H. Thomas, Roger Williams, W. Carman, 1991, Hepatology.

Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection

P. Klenerman, H. Thomas, M. Thursz, 2002, Genes and Immunity.

The precore sequence of hepatitis B virus is required for nuclear localization of the core protein

H. Thomas, S. Hadziyannis, P. Karayiannis, 1997, Hepatology.

Replication of Hepatitis B and Delta Viruses: Appearance of Viral Mutants

H. Thomas, G. Foster, W. Carman, 1991, Seminars in liver disease.

Fulminant hepatitis associated with hepatitis B virus e antigen–negative infection: Importance of host factors

H. Thomas, M. Thursz, S. Hadziyannis, 1995, Hepatology.

Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon‐treated patient

H. Thomas, W. Lim, J. Hou, 2001, Journal of viral hepatitis.

Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants

H. Thomas, G. Fattovich, A. Alberti, 1995, Journal of viral hepatitis.